Compassionate use of psychedelics
Greif, A., & Šurkala, M. | Medicine, Health Care, and Philosophy | 23 September 2020
P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap
Smigielski, L., Kometer, M., Scheidegger, M., Stress, C., Preller, K. H., Koenig, T., & Vollenweider, F. X. | Human brain mapping | 21 Aug 2020
Psychedelic science in post-COVID-19 psychiatry
Kelly, J. R., Crockett, M. T., Alexander, L., Haran, M., Baker, A., Burke, L., & O’Keane, V. | Irish journal of psychological medicine | 19 Aug 2020
Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
Galvão-Coelho, N. L., de Menezes Galvão, A. C., de Almeida, R. N., Palhano-Fontes, F., Campos Braga, I., Lobão Soares, B., de Araujo, D. B. | Journal of Psychopharmacology | 10 Jul 2020
Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans
Davis, A. K., Averill, L. A., Sepeda, N. D., Barsuglia, J. P., & Amoroso, T. | Chronic Stress | 8 July 2020
In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor
Pottie, E., Cannaert, A., & Stove, C. P | Archives of Toxicology | 5 July 2020
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil
Jardim, A. V., Jardim, D. V., Chaves, B. R., Steglich, M., Ot’alora G, M., Mithoefer, M. C., Doblin, R. | Brazilian Journal of Psychiatry | 3 July 2020
Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains
Varley, T. F., Carhart-Harris, R., Roseman, L., Menon, D. K., & Stamatakis, E. A. | NeuroImage | 30 June 2020
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
Shiroma, P. R., Thuras, P., Wels, J., Albott, C. S., Erbes, C., Tye, S., & Lim, K. O. | Translational psychiatry | 26 June 2020
Psilocybin occasioned mystical-type experiences
James, E., Robertshaw, T. L., Hoskins, M., & Sessa, B. | Human Psychopharmacology: Clinical and Experimental | 23 June 2020
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments
Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. | Expert Review of Clinical Pharmacology | 1 June 2020
Spotlight commentary: REBUS and the anarchic brain
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 12 June 2020
A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy
Luoma, J. B., Chwyl, C., Bathje, G. J., Davis, A. K., & Lancelotta, R. | Journal Of Psychoactive Drugs | 12 June 2020
Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland
Kangaslampi, S., Hausen, A., & Rauteenmaa, T. | Journal of Psychoactive Drugs | 8 June 2020
Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan
Carbonaro, T. M., Johnson, M. W., & Griffiths, R. R | Psychopharmacology | 5 June 2020
Broadening Your Mind to Include Others: The relationship between serotonergic psychedelic experiences and maladaptive narcissism
van Mulukom, V., Patterson, R., & van Elk, M. | Psychopharmacology (Berl) | 29 May 2020
Ethics and ego dissolution: the case of psilocybin
Smith, W. R., & Sisti, D. | Journal of Medical Ethics | 27 May 2020
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention
Barrett, F. S., Krimmel, S. R., Griffiths, R., Seminowicz, D. A., & Mathur, B. N. | NeuroImage | 23 May 2020
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
Mason, N. L., Kuypers, K. P. C., Müller, F., Reckweg, J., Tse, D. H. Y., Toennes, S. W., ... & Ramaekers, J. G. | Neuropsychopharmacology | 23 May 2020
Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I)
Fu, D. J., Ionescu, D. F., Li, X., Lane, R., Lim, P., Sanacora, G., ... & Canuso, C. M. | 12 May 2020 | The Journal of clinical psychiatry
MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t
Morgan, L. | Annals of General Psychiatry | 12 May 2020
Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances
Abbott, K. L., Gill, K. S., Flannery, P. C., Boothe, D. M., Dhanasekaran, M., & Pondugula, S. R. | ACS Chemical Neuroscience | 12 May 2020
Psilocybin: from ancient magic to modern medicine
Nichols, D. E. | The Journal of Antibiotics | 12 May 2020
Long-term Follow-Up Outcomes of MDMA-assisted Psychotherapy for Treatment of PTSD: A Longitudinal Pooled Analysis of Six Phase 2 Trials
Jerome, L., Feduccia, A. A., Wang, J. B., Hamilton, S., Yazar-Klosinski, B., Emerson, A., ... & Doblin, R. | Psychopharmacology | 11 May 2020
Psychedelic treatment of functional neurological disorder: a systematic review
Butler, M., Seynaeve, M., Nicholson, T. R., Pick, S., Kanaan, R. A., Lees, A., ... & Rucker, J. | Therapeutic Advances in Psychopharmacology | 11 May 2020